Determining method for evaluation gene groups for gastric cancer prognosis prediction
A technology for determining methods and genes, applied in the direction of biochemical equipment and methods, microbial determination/inspection, etc., can solve problems such as difficult application, no significant relationship, lack of evidence of genetic biological mechanism, etc., to reduce mutation frequency. limit, reduce the limit of robustness, evaluate the effect of high accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] figure 2 It is a flowchart of steps of the determination method involved in Embodiment 1 of the present invention.
[0049] This embodiment is to specifically illustrate the determination method of the evaluation gene group used for the prediction of the prognosis of gastric cancer, such as figure 2 As shown, the determination method specifically includes the following steps:
[0050] Step S1, determine the set of candidate target genes, specifically:
[0051] All the genes included in the RhoA protein activity regulation pathway are used as an alternative target gene set, specifically, the alternative target gene set in this embodiment is the regulatory gene of the RhoA protein activity regulation pathway verified by the experimental data in the NCI database, In this embodiment, a total of 48 regulatory genes were selected as the set of candidate target genes through the literature progress tracking and verification.
[0052] Step S2, determine the pending evaluat...
Embodiment 2
[0097] This example is to clarify the possible biological mechanism of the prognosis of the evaluation gene group (RhoA_S) determined in Example 1. For this reason, we perform functional enrichment on all genes that meet the predetermined mutation conditions in the RhoA_S of the good prognosis sample, and the results show The pathways mainly enriched for mutations in samples with good prognosis are shown in Table 3.
[0098]
[0099]
[0100] The results in Table 3 show the pathways with significantly enriched mutations in samples with good prognosis: the function number is the pathway number; the function description refers to the function corresponding to the pathway, or the function it plays; the number of pathway genes is the total number of genes in the corresponding pathway. number; the number of genes that meet the predetermined mutation conditions refers to the number of times that the genes that meet the predetermined condition mutations appear in the pathway in ...
Embodiment 3
[0110] This example is to confirm that the evaluation gene group obtained by the determination method in Example 1 can indeed be used as a clinical basis for prognosis prediction of gastric cancer.
[0111] In this example, we collected clinical samples of 61 cases of diffuse gastric cancer and 50 cases of intestinal type gastric cancer from Chinese patients. These samples are mainly concentrated in clinical stage II to III samples. The overall survival period of the disease, death and other clinical information such as gender, age, EBV, HER2 amplification and other information were collected (see Table 5).
[0112]
[0113]
[0114]
[0115]
[0116]
[0117]
[0118] DNA from these 111 clinical samples of gastric cancer was extracted, whole exome sequencing (results of exome sequencing) was performed on these samples, and then the sequencing results were processed.
[0119] Wherein, in the processing of the sequencing results in this embodiment, adapters a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com